What is Johnson & Johnson's xarelto — percent change (as a percent)?

Johnson & Johnson (JNJ) reported xarelto — percent change (as a percent) of -7.0% in Q1 2026.

How has Johnson & Johnson's xarelto — percent change (as a percent) changed year-over-year?

Johnson & Johnson's xarelto — percent change (as a percent) decreased by 121.0% year-over-year, from 33.3% to -7.0%.

What is the long-term trend for Johnson & Johnson's xarelto — percent change (as a percent)?

Over 2 years (2022 to 2024), Johnson & Johnson's xarelto — percent change (as a percent) has grown at a 153.3% compound annual growth rate (CAGR), from 2.4% to -15.4%.

What does xarelto — percent change (as a percent) mean?

The percentage growth or decline in revenue for a specific product compared to a prior period.

Products & Services · Percent Change (as a percent)

XARELTO — Percent Change (as a percent)

Johnson & Johnson XARELTO — Percent Change (as a percent) decreased by 194.6% to -7.0% in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 121.0%, from 33.3% to -7.0%. Over 2 years (FY 2022 to FY 2024), XARELTO — Percent Change (as a percent) shows a downward trend with a 153.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityVolatile

First reportedQ1 2018

Last reportedQ1 2026Apr 22, 2026

How to read this metric

A positive percentage indicates growth and market share expansion, whereas a negative percentage suggests market saturation, loss of exclusivity, or competitive displacement.

Detailed definition

This metric measures the period-over-period growth rate of revenue for a specific pharmaceutical product line. It provid...

Peer comparison

Comparable to year-over-year or sequential growth rate metrics reported for key therapeutic assets by peer pharmaceutical firms.

Metric ID: jnj_segment_xarelto_percent_change_as_a_percent

Historical Data

18 periods

	Q2 '21	Q3 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q1 '26
Value	1.8%	0.8%	-13.8%	7.1%	8.4%	0.7%	13.7%	4.7%	-9.4%	-6.3%	-10.4%	-7.9%	-5.2%	8.1%	33.3%	5.6%	7.4%	-7%
QoQ Change	—	-55.6%	<-999%	+151.4%	+18.3%	-91.7%	>999%	-65.7%	-300.0%	+33.0%	-65.1%	+24.0%	+34.2%	+255.8%	+311.1%	-83.2%	+32.1%	-194.6%
YoY Change	—	—	—	+294.4%	+950.0%	—	+199.3%	-33.8%	-211.9%	<-999%	-175.9%	-268.1%	+44.7%	+228.6%	+420.2%	+170.9%	+242.3%	-121.0%

Range-13.8% – 33.3%

CAGR+37.7%

Avg YoY Growth+52.8%

Median YoY Growth+107.8%

Similar Metrics at Other Companies

Natera, Inc.NTRA View metric

Gilead SciencesGILD View metric

EquifaxEFX View metric

ROP

Roper Technologies, Inc.ROP View metric

EquifaxEFX View metric

ROP

Roper Technologies, Inc.ROP View metric

Frequently Asked Questions

What is Johnson & Johnson's xarelto — percent change (as a percent)?: Johnson & Johnson (JNJ) reported xarelto — percent change (as a percent) of -7.0% in Q1 2026.
How has Johnson & Johnson's xarelto — percent change (as a percent) changed year-over-year?: Johnson & Johnson's xarelto — percent change (as a percent) decreased by 121.0% year-over-year, from 33.3% to -7.0%.
What is the long-term trend for Johnson & Johnson's xarelto — percent change (as a percent)?: Over 2 years (2022 to 2024), Johnson & Johnson's xarelto — percent change (as a percent) has grown at a 153.3% compound annual growth rate (CAGR), from 2.4% to -15.4%.
What does xarelto — percent change (as a percent) mean?: The percentage growth or decline in revenue for a specific product compared to a prior period.